Research / ENTG / Fundamental state Inspectable configuration
State dimensions Filing 0001101302-18-000045 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
169.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.89% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.66% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
16.43% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
69.27% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
47.61% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
19.56% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.89% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.16% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Mar 30, 2019 0/9 normalized Level 3 Jun 29, 2019 8/9 normalized Level 3 Sep 28, 2019 8/9 normalized Level 3 Dec 31, 2019 8/9 normalized Level 3 Mar 28, 2020 8/9 normalized Level 3 Jun 27, 2020 9/9 normalized Level 3 Sep 26, 2020 9/9 normalized Level 3 Dec 31, 2020 9/9 normalized Level 3 Apr 3, 2021 9/9 normalized Level 3 Jul 3, 2021 9/9 normalized Level 3 Oct 2, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Apr 2, 2022 9/9 normalized Level 3 Jul 2, 2022 9/9 normalized Level 3 Oct 1, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Apr 1, 2023 9/9 normalized Level 3 Jul 1, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Sep 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 176.97%
Current 169.74%
Delta -7.22% Capex Intensity Increased
Previous 5.73%
Current 6.89%
Delta 1.16% Cash Generation Increased
Previous 10.57%
Current 25.66%
Delta 15.09% Inventory Pressure Increased
Previous 58.32%
Current 69.27%
Delta 10.95% Margin Decreased
Previous 47.93%
Current 47.61%
Delta -0.32% Profitability Decreased
Previous 21.37%
Current 19.56%
Delta -1.81% R And D Intensity Increased
Previous 7.51%
Current 7.89%
Delta 0.38% Sbc Intensity Increased
Previous 1.12%
Current 1.16%
Delta 0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.